A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma

BackgroundRetinoblastoma is a rare pediatric eye cancer caused by mutations in the RB1 gene, which regulates retinal cell growth. Early detection and treatment are critical for preventing vision loss and improving survival outcomes. This study aimed to perform an integrated proteotranscriptomic char...

Full description

Saved in:
Bibliographic Details
Main Authors: Julian Wolf, Rozina Ida Hajdu, Stefaniya Boneva, Ira Godbole, Lucas Stürzbecher, Claudia Auw-Haedrich, Wolf A. Lagrèze, Hansjürgen Agostini, Thomas Reinhard, Stefan Tholen, Oliver Schilling, Günther Schlunck, Bertram Bengsch, Clemens Lange
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1571702/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312695631740928
author Julian Wolf
Rozina Ida Hajdu
Stefaniya Boneva
Ira Godbole
Lucas Stürzbecher
Claudia Auw-Haedrich
Wolf A. Lagrèze
Hansjürgen Agostini
Thomas Reinhard
Stefan Tholen
Oliver Schilling
Günther Schlunck
Bertram Bengsch
Clemens Lange
author_facet Julian Wolf
Rozina Ida Hajdu
Stefaniya Boneva
Ira Godbole
Lucas Stürzbecher
Claudia Auw-Haedrich
Wolf A. Lagrèze
Hansjürgen Agostini
Thomas Reinhard
Stefan Tholen
Oliver Schilling
Günther Schlunck
Bertram Bengsch
Clemens Lange
author_sort Julian Wolf
collection DOAJ
description BackgroundRetinoblastoma is a rare pediatric eye cancer caused by mutations in the RB1 gene, which regulates retinal cell growth. Early detection and treatment are critical for preventing vision loss and improving survival outcomes. This study aimed to perform an integrated proteotranscriptomic characterization of human retinoblastoma to provide a deeper understanding of disease biology and to identify novel therapeutic targets.MethodsPaired tumor and adjacent retinal tissue samples were dissected from seven eyes. RNA sequencing and liquid chromatography-mass spectrometry were performed on the same samples. The spatially resolved cellular landscape was assessed using Imaging Mass Cytometry (IMC).ResultsThe correlation between RNA and protein level was moderate with variations across different pathways, underscoring the value of an integrated proteotranscriptomic approach. IMC identified more than 67,000 single cells in 11 distinct clusters, including antigen presenting cells, T cells, stroma cells, vascular cells and two clusters of proliferating and CD44/c-Myc positive tumor cells. Antigen presenting cells expressed higher levels of CD68 in retinoblastoma compared to controls. ConclusionsCD44+ and high-c-Myc-expressing tumor cells may represent cancer stem cells with possible involvement in metastasis, warranting further validation. Our multilayered approach could pave the way for enhanced molecular assessments and novel targeted therapies for human retinoblastoma.
format Article
id doaj-art-e797eb81ad1a4e23a999e2e7efbd322d
institution Kabale University
issn 2234-943X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-e797eb81ad1a4e23a999e2e7efbd322d2025-08-20T03:53:01ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-05-011510.3389/fonc.2025.15717021571702A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastomaJulian Wolf0Rozina Ida Hajdu1Stefaniya Boneva2Ira Godbole3Lucas Stürzbecher4Claudia Auw-Haedrich5Wolf A. Lagrèze6Hansjürgen Agostini7Thomas Reinhard8Stefan Tholen9Oliver Schilling10Günther Schlunck11Bertram Bengsch12Clemens Lange13Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyClinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute of Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute of Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyEye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyClinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, GermanyOphtha-Lab, Department of Ophthalmology, St. Franziskus Hospital, Münster, GermanyBackgroundRetinoblastoma is a rare pediatric eye cancer caused by mutations in the RB1 gene, which regulates retinal cell growth. Early detection and treatment are critical for preventing vision loss and improving survival outcomes. This study aimed to perform an integrated proteotranscriptomic characterization of human retinoblastoma to provide a deeper understanding of disease biology and to identify novel therapeutic targets.MethodsPaired tumor and adjacent retinal tissue samples were dissected from seven eyes. RNA sequencing and liquid chromatography-mass spectrometry were performed on the same samples. The spatially resolved cellular landscape was assessed using Imaging Mass Cytometry (IMC).ResultsThe correlation between RNA and protein level was moderate with variations across different pathways, underscoring the value of an integrated proteotranscriptomic approach. IMC identified more than 67,000 single cells in 11 distinct clusters, including antigen presenting cells, T cells, stroma cells, vascular cells and two clusters of proliferating and CD44/c-Myc positive tumor cells. Antigen presenting cells expressed higher levels of CD68 in retinoblastoma compared to controls. ConclusionsCD44+ and high-c-Myc-expressing tumor cells may represent cancer stem cells with possible involvement in metastasis, warranting further validation. Our multilayered approach could pave the way for enhanced molecular assessments and novel targeted therapies for human retinoblastoma.https://www.frontiersin.org/articles/10.3389/fonc.2025.1571702/fullretinoblastomatranscriptomicsproteomicsIMCproteotranscriptomicstranslational medicine
spellingShingle Julian Wolf
Rozina Ida Hajdu
Stefaniya Boneva
Ira Godbole
Lucas Stürzbecher
Claudia Auw-Haedrich
Wolf A. Lagrèze
Hansjürgen Agostini
Thomas Reinhard
Stefan Tholen
Oliver Schilling
Günther Schlunck
Bertram Bengsch
Clemens Lange
A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
Frontiers in Oncology
retinoblastoma
transcriptomics
proteomics
IMC
proteotranscriptomics
translational medicine
title A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
title_full A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
title_fullStr A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
title_full_unstemmed A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
title_short A proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
title_sort proteotranscriptomic approach to dissect the molecular landscape of human retinoblastoma
topic retinoblastoma
transcriptomics
proteomics
IMC
proteotranscriptomics
translational medicine
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1571702/full
work_keys_str_mv AT julianwolf aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT rozinaidahajdu aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT stefaniyaboneva aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT iragodbole aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT lucassturzbecher aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT claudiaauwhaedrich aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT wolfalagreze aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT hansjurgenagostini aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT thomasreinhard aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT stefantholen aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT oliverschilling aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT guntherschlunck aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT bertrambengsch aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT clemenslange aproteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT julianwolf proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT rozinaidahajdu proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT stefaniyaboneva proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT iragodbole proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT lucassturzbecher proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT claudiaauwhaedrich proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT wolfalagreze proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT hansjurgenagostini proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT thomasreinhard proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT stefantholen proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT oliverschilling proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT guntherschlunck proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT bertrambengsch proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma
AT clemenslange proteotranscriptomicapproachtodissectthemolecularlandscapeofhumanretinoblastoma